Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024925003894 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1839604013830504448 |
---|---|
author | Andrea Angeletti Gianluca Caridi Xhuliana Kajana Carolina Bigatti Agnese Spennacchio Decimo Silvio Chiarenza Gabriele Mortari Paolo Cravedi Enrico E. Verrina |
author_facet | Andrea Angeletti Gianluca Caridi Xhuliana Kajana Carolina Bigatti Agnese Spennacchio Decimo Silvio Chiarenza Gabriele Mortari Paolo Cravedi Enrico E. Verrina |
author_sort | Andrea Angeletti |
collection | DOAJ |
format | Article |
id | doaj-art-46aa2a25a6ee45ac835b72affa5b5b51 |
institution | Matheson Library |
issn | 2468-0249 |
language | English |
publishDate | 2025-08-01 |
publisher | Elsevier |
record_format | Article |
series | Kidney International Reports |
spelling | doaj-art-46aa2a25a6ee45ac835b72affa5b5b512025-08-02T04:47:28ZengElsevierKidney International Reports2468-02492025-08-0110828732874Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center ExperienceAndrea Angeletti0Gianluca Caridi1Xhuliana Kajana2Carolina Bigatti3Agnese Spennacchio4Decimo Silvio Chiarenza5Gabriele Mortari6Paolo Cravedi7Enrico E. Verrina8Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Correspondence: Andrea Angeletti, Nephrology, Dialysis and Transplantation; IRCCS Istituto Giannina Gaslini, Via Gaslini 5, 16147 Genova GE, Italy.Nephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy; Department of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USANephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyNephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, ItalyDepartment of Medicine, Translational Transplant Research Center, Icahn School of Medicine at Mount Sinai, New York, New York, USANephrology, Dialysis and Transplantation Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italyhttp://www.sciencedirect.com/science/article/pii/S2468024925003894 |
spellingShingle | Andrea Angeletti Gianluca Caridi Xhuliana Kajana Carolina Bigatti Agnese Spennacchio Decimo Silvio Chiarenza Gabriele Mortari Paolo Cravedi Enrico E. Verrina Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience Kidney International Reports |
title | Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience |
title_full | Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience |
title_fullStr | Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience |
title_full_unstemmed | Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience |
title_short | Obinutuzumab in Rituximab-Resistant Podocytopathies: A Single-Center Experience |
title_sort | obinutuzumab in rituximab resistant podocytopathies a single center experience |
url | http://www.sciencedirect.com/science/article/pii/S2468024925003894 |
work_keys_str_mv | AT andreaangeletti obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT gianlucacaridi obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT xhulianakajana obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT carolinabigatti obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT agnesespennacchio obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT decimosilviochiarenza obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT gabrielemortari obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT paolocravedi obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience AT enricoeverrina obinutuzumabinrituximabresistantpodocytopathiesasinglecenterexperience |